PDP-AMANTADINE HYDROCHLORIDE CAPSULES DIN 01990403
Status: Marketed
Holder: PENDOPHARM DIVISION OF PHARMASCIENCE INC
Molecule: AMANTADINE HYDROCHLORIDE
Available to quote
Health Canada record
| Active ingredient(s) | AMANTADINE HYDROCHLORIDE 100 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N04BB01 AMANTADINE |
| Original market date | 31-Dec-1992 |
| Current status date | 15-Mar-2017 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing AMANTADINE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02538601 | ODAN-AMANTADINE SYRUP | ODAN LABORATORIESLTD | Syrup | AMANTADINE HYDROCHLORIDE 10 MG | Marketed |
| 02022826 | PDP-AMANTADINE HYDROCHLORIDE SYRUP | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Syrup | AMANTADINE HYDROCHLORIDE 50 MG | Marketed |
| 02130963 | DOM-AMANTADINE HYDROCHLORIDE CAPSULES-100MG | DOMINION PHARMACAL | Capsule | AMANTADINE HYDROCHLORIDE 100 MG | Cancelled Post Market |
| 02034468 | ENDANTADINE | BRISTOL-MYERS SQUIBB CANADA | Capsule | AMANTADINE HYDROCHLORIDE 100 MG | Cancelled Post Market |
| 01919288 | ENDANTADINE CAP 100MG | DUPONT MERCK PHARMA INC. | Capsule | AMANTADINE HYDROCHLORIDE 100 MG | Cancelled Post Market |
| 02199289 | MED-AMANTIDINE - CAP 100MG | MEDICAN PHARMA INCORPORATED | Capsule | AMANTADINE HYDROCHLORIDE 100 MG | Cancelled Post Market |
| 02139200 | MYLAN-AMANTADINE | MYLAN PHARMACEUTICALS ULC | Capsule | AMANTADINE HYDROCHLORIDE 100 MG | Cancelled Post Market |
| 02238306 | PHL-AMANTADINE | PHARMEL INC | Capsule | AMANTADINE HYDROCHLORIDE 100 MG | Cancelled Post Market |
| 02262649 | PHL-AMANTADINE SYRUP 10MG/ML | PHARMEL INC | Syrup | AMANTADINE HYDROCHLORIDE 10 MG | Cancelled Post Market |
| 02494140 | PMS-AMANTADINE HYDROCHLORIDE CAPSULES | PHARMASCIENCE INC | Capsule | AMANTADINE HYDROCHLORIDE 100 MG | Cancelled Pre Market |
| 02494159 | PMS-AMANTADINE HYDROCHLORIDE SYRUP | PHARMASCIENCE INC | Syrup | AMANTADINE HYDROCHLORIDE 50 MG | Cancelled Pre Market |
| 01914006 | SYMMETREL CAPSULES 100MG | BRISTOL-MYERS SQUIBB CANADA | Capsule | AMANTADINE HYDROCHLORIDE 100 MG | Cancelled Post Market |
| 01913999 | SYMMETREL SYRUP 10MG/ML | BRISTOL-MYERS SQUIBB CANADA | Syrup | AMANTADINE HYDROCHLORIDE 10 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 27209 | 2021-12-10 | Supplement to a New Drug Submission (SNDS) | Update to the Product Monograph and migrate the Product Monograph to the 2020 format |
| 19055 | 2017-03-13 | New Drug Submission (NDS) | TRANSFER OF DRUG IDENTIFICATION NUMBERS |
International API supply for AMANTADINE HYDROCHLORIDE
3 valid EDQM Certificates of Suitability from 3 holders. 5 active FDA Drug Master Files.
Request a quote for PDP-AMANTADINE HYDROCHLORIDE CAPSULES